NOTE: Some edits were made (10/27/12) after eagle eyed commenter Richard Trent pointed out some flaws in my summary which I have tried to correct below. Sarepta Pharamaceuticals recently released data …
Continue Reading about A New Drug For Duchenne Muscular Dystrophy: Cause for Cautious Optimism →